TOP1 and small cell lung carcinoma: Molecular assessment of pre‐ and post‐treatment SCLC cell lines in this study provides a framework to understand the molecular mechanism of duo‐inhibition of ATR and TOP1 and paves a way for the development of new therapeutic strategy for SCLC.